CYBA encoding p22phox, the cytochrome b558 alpha polypeptide: Gene structure, expression, role and physiopathology

Gene

Volumn 586, Issue 1, 2016, Pages 27-35

  Stasia, Marie José ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

CGD; CYBA; NADPH oxidase; NOX; P22phox; Polymorphism; Vascular

Indexed keywords

CYTOCHROME B558; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CYBA PROTEIN, HUMAN;

DISEASE SEVERITY; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC VARIATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC GRANULOMATOUS DISEASE; GENETICS; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84964893806     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.03.050     Document Type: Review

References (93)

1. Ambasta R.K., Kumar P., Griendling K.K., Schmidt H.H., Busse R., Brandes R.P. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 2004, 279:45935-45941.
2. Arca M., Conti B., Montali A., Pignatelli P., Campagna F., Barilla F., Tanzilli G., Verna R., Vestri A., Gaudio C., Violi F. C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2008, 28:752-757.
3. Bakri F.G., Martel C., Khuri-Bulos N., Mahafzah A., El-Khateeb M.S., Al-Wahadneh A.M., Hayajneh W.A., Hamamy H.A., Maquet E., Molin M., Stasia M.J. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J. Clin. Immunol. 2009, 29:215-230.
4. Banfi B., Malgrange B., Knisz J., Steger K., Dubois-Dauphin M., Krause K.H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 2004, 279:46065-46072.
5. Batot G., Paclet M.H., Doussiere J., Vergnaud S., Martel C., Vignais P.V., Morel F. Biochemical and immunochemical properties of B lymphocyte cytochrome b558. Biochim. Biophys. Acta 1998, 1406:188-202.
6. Beaumel S., Grunwald D., Fieschi F., Stasia M.J. Identification of NOX2 regions for normal biosynthesis of cytochrome b558 in phagocytes highlighting essential residues for p22phox binding. Biochem. J. 2014, 464:425-437.
7. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
8. Bedard K., Attar H., Bonnefont J., Jaquet V., Borel C., Plastre O., Stasia M.J., Antonarakis S.E., Krause K.H. Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum. Mutat. 2009, 30:1123-1133.
9. Biberstine-Kinkade K.J., DeLeo F.R., Epstein R.I., LeRoy B.A., Nauseef W.M., Dinauer M.C. Heme-ligating histidines in flavocytochrome b(558): identification of specific histidines in gp91(phox). J. Biol. Chem. 2001, 276:31105-31112.
10. Bousfiha A.A., Jeddane L., El Hafidi N., Benajiba N., Rada N., El Bakkouri J., Kili A., Benmiloud S., Benhsaien I., Faiz I., Maataoui O., Aadam Z., Aglaguel A., Baba L.A., Jouhadi Z., Abilkassem R., Bouskraoui M., Hida M., Najib J., Alj H.S., Ailal F., Moroccan Society for Primary, I. First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012). J. Clin. Immunol. 2014, 34:459-468.
11. Brault J., Goutagny E., Telugu N., Shao K., Baquie M., Satre V., Coutton C., Grunwald D., Brion J.P., Barlogis V., Stephan J.L., Plantaz D., Hescheler J., Krause K.H., Saric T., Stasia M.J. Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases. Biores. Open Access 2014, 3:311-326.
12. Bu-Ghanim H.N., Casimir C.M., Povey S., Segal A.W. The alpha subunit of cytochrome b-245 mapped to chromosome 16. Genomics 1990, 8:568-570.
13. Burritt J.B., Busse S.C., Gizachew D., Siemsen D.W., Quinn M.T., Bond C.W., Dratz E.A., Jesaitis A.J. Antibody imprint of a membrane protein surface. Phagocyte flavocytochrome b. J Biol Chem 1998, 273:24847-24852.
14. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269:131-140.
15. Dahan I., Issaeva I., Gorzalczany Y., Sigal N., Hirshberg M., Pick E. Mapping of functional domains in the p22(phox) subunit of flavocytochrome b(559) participating in the assembly of the NADPH oxidase complex by "peptide walking". J. Biol. Chem. 2002, 277:8421-8432.
16. Dang P.M., Raad H., Derkawi R.A., Boussetta T., Paclet M.H., Belambri S.A., Makni-Maalej K., Kroviarski Y., Morel F., Gougerot-Pocidalo M.A., El-Benna J. The NADPH oxidase cytosolic component p67phox is constitutively phosphorylated in human neutrophils: Regulation by a protein tyrosine kinase, MEK1/2 and phosphatases 1/2A. Biochem. Pharmacol. 2011, 82:1145-1152.
17. de Boer M., de Klein A., Hossle J.P., Seger R., Corbeel L., Weening R.S., Roos D. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). Am. J. Hum. Genet. 1992, 51:1127-1135.
18. DeLeo F.R., Burritt J.B., Yu L., Jesaitis A.J., Dinauer M.C., Nauseef W.M. Processing and maturation of flavocytochrome b558 include incorporation of heme as a prerequisite for heterodimer assembly. J. Biol. Chem. 2000, 275:13986-13993.
19. Dinauer M.C., Orkin S.H., Brown R., Jesaitis A.J., Parkos C.A. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987, 327:717-720.
20. Dinauer M.C., Pierce E.A., Bruns G.A., Curnutte J.T., Orkin S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 1990, 86:1729-1737.
21. Doi K., Noiri E., Nakao A., Fujita T., Kobayashi S., Tokunaga K. Haplotype analysis of NAD(P)H oxidase p22phox polymorphisms in end-stage renal disease. J. Hum. Genet. 2005, 50:641-647.
22. El Kares R., Barbouche M.R., Elloumi-Zghal H., Bejaoui M., Chemli J., Mellouli F., Tebib N., Abdelmoula M.S., Boukthir S., Fitouri Z., M'Rad S., Bouslama K., Touiri H., Abdelhak S., Dellagi M.K. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J. Hum. Genet. 2006, 51:887-895.
23. El-Benna J., Dang P.M., Gougerot-Pocidalo M.A., Marie J.C., Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp. Mol. Med. 2009, 41:217-225.
24. Fang S., Wang L., Jia C. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis. Thromb. Res. 2010, 125:e197-e201.
25. Franko B., Benhamou P.Y., Genty C., Jouve T., Nasse L., Rzeoecki V., Semeraro P., Stasia M.J., Zaoui P. RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-up. Acta Diabetol. 2015.
26. Fukui T., Lassegue B., Kai H., Alexander R.W., Griendling K.K. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim. Biophys. Acta 1995, 1231:215-219.
27. Gardemann A., Mages P., Katz N., Tillmanns H., Haberbosch W. The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999, 145:315-323.
28. Groemping Y., Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem. J. 2005, 386:401-416.
29. Groemping Y., Lapouge K., Smerdon S.J., Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 2003, 113:343-355.
30. Gu L., Su L., Liang B., Tang N., Long J., Tan J., Chen Q., Xie J., Wu G., Yan Y., Huang G., Zu X. Association between the C242T polymorphism of p22phox gene and ischemic stroke: a meta-analysis. J. Neurol. Sci. 2013, 330:100-110.
31. Harper A.M., Dunne M.J., Segal A.W. Purification of cytochrome b-245 from human neutrophils. Biochem. J. 1984, 219:519-527.
32. Hu P., Huang M.Y., Hu X.Y., Xie X.J., Xiang M.X., Liu X.B., Wang J.A. Meta-analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians. J. Zhejiang Univ. Sci. B 2015, 16:370-379.
33. Imajoh-Ohmi S., Tokita K., Ochiai H., Nakamura M., Kanegasaki S. Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. J. Biol. Chem. 1992, 267:180-184.
34. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
35. Jakobsen M.A., Katzenstein T.L., Valerius N.H., Roos D., Fisker N., Mogensen T.H., Jensen P.O., Barington T. Genetical analysis of all Danish patients diagnosed with chronic granulomatous disease. Scand. J. Immunol. 2012, 76:505-511.
36. Katakami N., Kaneto H., Matsuoka T.A., Takahara M., Osonoi T., Saitou M., Kawai K., Ishibashi F., Kashiwagi A., Kawamori R., Shimomura I., Yamasaki Y. Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes-an 8-year prospective study. Atherosclerosis 2014, 235:408-414.
37. Koker M.Y., Camcioglu Y., van Leeuwen K., Kilic S.S., Barlan I., Yilmaz M., Metin A., de Boer M., Avcilar H., Patiroglu T., Yildiran A., Yegin O., Tezcan I., Sanal O., Roos D. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J. Allergy Clin. Immunol. 2013, 132:1156-1163. (e5).
38. Koker M.Y., van Leeuwen K., de Boer M., Celmeli F., Metin A., Ozgur T.T., Tezcan I., Sanal O., Roos D. Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Eur. J. Clin. Investig. 2009, 39:311-319.
39. Krause K.H., Lambeth D., Kronke M. NOX enzymes as drug targets. Cell. Mol. Life Sci. 2012, 69:2279-2282.
40. Kuhns D.B., Alvord W.G., Heller T., Feld J.J., Pike K.M., Marciano B.E., Uzel G., DeRavin S.S., Priel D.A., Soule B.P., Zarember K.A., Malech H.L., Holland S.M., Gallin J.I. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 2010, 363:2600-2610.
41. Lambeth J.D., Neish A.S. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu. Rev. Pathol. 2014, 9:119-145.
42. Leto T.L., Adams A.G., de Mendez I. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10650-10654.
43. Leusen J.H., Bolscher B.G., Hilarius P.M., Weening R.S., Kaulfersch W., Seger R.A., Roos D., Verhoeven A.J. 156Pro->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J. Exp. Med. 1994, 180:2329-2334.
44. Lewis E.M., Sergeant S., Ledford B., Stull N., Dinauer M.C., McPhail L.C. Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding. J. Biol. Chem. 2010, 285:2959-2967.
45. Li B.H., Zhang L.L., Zhang B.B., Yin Y.W., Dai L.M., Pi Y., Guo L., Gao C.Y., Fang C.Q., Wang J.Z., Li J.C. Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis. PLoS One 2013, 8:e56478.
46. Li P., Qiu T., Qin C. NADPH oxidase p22phox C242T polymorphism and ischemic cerebrovascular disease: an updated meta-analysis. Med. Sci. Monit. 2015, 21:231-238.
47. Liang B., Wei Q., Shen T., Su L., Yan Y., Wu G., Lu J., Gu L. The A640G polymorphism in the NAD(P)H oxidase p22phox gene (CYBA) is associated with risk reduction of coronary heart disease: a meta-analysis. Clin. Biochem. 2014, 47:409-416.
48. Maly F.E., Schuerer-Maly C.C., Quilliam L., Cochrane C.G., Newburger P.E., Curnutte J.T., Gifford M., Dinauer M.C. Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA. J. Exp. Med. 1993, 178:2047-2053.
49. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 2006, 18:69-82.
50. Meijles D.N., Howlin B.J., Li J.M. Consensus in silico computational modelling of the p22phox subunit of the NADPH oxidase. Comput. Biol. Chem. 2012, 39:6-13.
51. Moreno M.U., Zalba G. CYBA gene variants as biomarkers for coronary artery disease. Drug News Perspect. 2010, 23:316-324.
52. Moreno M.U., San Jose G., Fortuno A., Beloqui O., Redon J., Chaves F.J., Corella D., Diez J., Zalba G. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension. J. Hypertens. 2007, 25:1620-1626.
53. Moreno M.U., San Jose G., Orbe J., Paramo J.A., Beloqui O., Diez J., Zalba G. Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett. 2003, 542:27-31.
54. Mori M., Li G., Hashimoto M., Nishio A., Tomozawa H., Suzuki N., Usami S., Higuchi K., Matsumoto K. Pivotal Advance: Eosinophilia in the MES rat strain is caused by a loss-of-function mutation in the gene for cytochrome b(-245), alpha polypeptide (Cyba). J. Leukoc. Biol. 2009, 86:473-478.
55. Nakano Y., Banfi B., Jesaitis A.J., Dinauer M.C., Allen L.A., Nauseef W.M. Critical roles for p22phox in the structural maturation and subcellular targeting of Nox3. Biochem. J. 2007, 403:97-108.
56. Nakano Y., Longo-Guess C.M., Bergstrom D.E., Nauseef W.M., Jones S.M., Banfi B. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J. Clin. Invest. 2008, 118:1176-1185.
57. Nathan C., Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 2013, 13:349-361.
58. Nikitin A.G., Chistiakov D.A., Minushkina L.O., Zateyshchikov D.A., Nosikov V.V. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart Vessel. 2010, 25:229-236.
59. Ogura K., Nobuhisa I., Yuzawa S., Takeya R., Torikai S., Saikawa K., Sumimoto H., Inagaki F. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide. J. Biol. Chem. 2006, 281:3660-3668.
60. Paffenholz R., Bergstrom R.A., Pasutto F., Wabnitz P., Munroe R.J., Jagla W., Heinzmann U., Marquardt A., Bareiss A., Laufs J., Russ A., Stumm G., Schimenti J.C., Bergstrom D.E. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev. 2004, 18:486-491.
61. Parkos C.A., Allen R.A., Cochrane C.G., Jesaitis A.J. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J. Clin. Investig. 1987, 80:732-742.
62. Parkos C.A., Dinauer M.C., Jesaitis A.J., Orkin S.H., Curnutte J.T. Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 1989, 73:1416-1420.
63. Parkos C.A., Dinauer M.C., Walker L.E., Allen R.A., Jesaitis A.J., Orkin S.H. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:3319-3323.
64. Patente T.A., Mohammedi K., Bellili-Munoz N., Driss F., Sanchez M., Fumeron F., Roussel R., Hadjadj S., Correa-Giannella M.L., Marre M., Velho G. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. Free Radic. Biol. Med. 2015, 86:16-24.
65. Pettit A.I., Wong R.K., Lee V., Jennings S., Quinn P.A., Ng L.L. Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22(phox) in lymphoblast cell lines. J. Hypertens. 2002, 20:677-683.
66. Porter C.D., Parkar M.H., Verhoeven A.J., Levinsky R.J., Collins M.K., Kinnon C. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox. Blood 1994, 84:2767-2775.
67. Qin Y.W., Peng J., Liang B.Y., Su L., Chen Q., Xie J.J., Gu L. The A930G polymorphism ofP22phox (CYBA) gene but not C242T variation is associated with hypertension: a meta-analysis. PLoS One 2013, 8.
68. Quinn M.T., Mullen M.L., Jesaitis A.J. Human neutrophil cytochrome b contains multiple hemes. Evidence for heme associated with both subunits. J. Biol. Chem. 1992, 267:7303-7309.
69. Raad H., Paclet M.H., Boussetta T., Kroviarski Y., Morel F., Quinn M.T., Gougerot-Pocidalo M.A., Dang P.M., El-Benna J. Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox. FASEB J. 2009, 23:1011-1022.
70. Rae J., Noack D., Heyworth P.G., Ellis B.A., Curnutte J.T., Cross A.R. Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 2000, 96:1106-1112.
71. Roos D., Kuhns D.B., Maddalena A., Bustamante J., Kannengiesser C., de Boer M., van Leeuwen K., Koker M.Y., Wolach B., Roesler J., Malech H.L., Holland S.M., Gallin J.I., Stasia M.J. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol. Dis. 2010, 44:291-299.
72. Roos D., Kuhns D.B., Maddalena A., Roesler J., Lopez J.A., Ariga T., Avcin T., de Boer M., Bustamante J., Condino-Neto A., Di Matteo G., He J., Hill H.R., Holland S.M., Kannengiesser C., Koker M.Y., Kondratenko I., van Leeuwen K., Malech H.L., Marodi L., Nunoi H., Stasia M.J., Ventura A.M., Witwer C.T., Wolach B., Gallin J.I. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol. Dis. 2010, 45:246-265.
73. San Jose G., Fortuno A., Beloqui O., Diez J., Zalba G. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin. Sci. (Lond.) 2008, 114:173-182.
74. Segal A.W., Harper A., Garcia R., Jones O.T., Cross A.R. The nature and function of the microbicidal oxidase system of neutrophils. Bull. Eur. Physiopathol. Respir. 1981, 17(Suppl.):187-191.
75. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 2008, 275:3249-3277.
76. Sumimoto H., Hata K., Mizuki K., Ito T., Kage Y., Sakaki Y., Fukumaki Y., Nakamura M., Takeshige K. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J. Biol. Chem. 1996, 271:22152-22158.
77. Taylor R.M., Baniulis D., Burritt J.B., Gripentrog J.M., Lord C.I., Riesselman M.H., Maaty W.S., Bothner B.P., Angel T.E., Dratz E.A., Linton G.F., Malech H.L., Jesaitis A.J. Analysis of human phagocyte flavocytochrome b(558) by mass spectrometry. J. Biol. Chem. 2006, 281:37045-37056.
78. Taylor R.M., Burritt J.B., Baniulis D., Foubert T.R., Lord C.I., Dinauer M.C., Parkos C.A., Jesaitis A.J. Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit. J. Immunol. 2004, 173:7349-7357.
79. Taylor R.M., Dratz E.A., Jesaitis A.J. Invariant local conformation in p22phox p.Y72H polymorphisms suggested by mass spectral analysis of crosslinked human neutrophil flavocytochrome b. Biochimie 2011, 93:1502-1509.
80. Teahan C., Rowe P., Parker P., Totty N., Segal A.W. The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature 1987, 327:720-721.
81. Teimourian S., Zomorodian E., Badalzadeh M., Pouya A., Kannengiesser C., Mansouri D., Cheraghi T., Parvaneh N. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. Br. J. Haematol. 2008, 141:848-851.
82. van den Berg J.M., van Koppen E., Ahlin A., Belohradsky B.H., Bernatowska E., Corbeel L., Espanol T., Fischer A., Kurenko-Deptuch M., Mouy R., Petropoulou T., Roesler J., Seger R., Stasia M.J., Valerius N.H., Weening R.S., Wolach B., Roos D., Kuijpers T.W. Chronic granulomatous disease: the European experience. PLoS One 2009, 4:e5234.
83. von Lohneysen K., Noack D., Jesaitis A.J., Dinauer M.C., Knaus U.G. Mutational analysis reveals distinct features of the Nox4-p22 phox complex. J. Biol. Chem. 2008, 283:35273-35282.
84. von Lohneysen K., Noack D., Wood M.R., Friedman J.S., Knaus U.G. Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization. Mol. Cell. Biol. 2010, 30:961-975.
85. Wolach B., Gavrieli R., de Boer M., Gottesman G., Ben-Ari J., Rottem M., Schlesinger Y., Grisaru-Soen G., Etzioni A., Roos D. Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients. Clin. Immunol. 2008, 129:103-114.
86. Wu Z., Lou Y., Jin W., Liu Y., Lu L., Chen Q., Xie Y., Lu G. Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis. PLoS One 2013, 8:e70885.
87. Xu H., Tian W., Li S.J., Zhang L.Y., Liu W., Zhao Y., Zhang Z.Y., Tang X.M., Wang M., Wu D.Q., Shi J.S., Ding Y., Zhao X.D., Yang X.Q., Jiang L.P. Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china. J. Clin. Immunol. 2014, 34:633-641.
88. Xu Q., Yuan F., Shen X., Wen H., Li W., Cheng B., Wu J. Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: a meta-analysis. PLoS One 2014, 9:e84251.
89. Yu L., DeLeo F.R., Biberstine-Kinkade K.J., Renee J., Nauseef W.M., Dinauer M.C. Biosynthesis of flavocytochrome b558. gp91(phox) is synthesized as a 65-kDa precursor (p65) in the endoplasmic reticulum. J. Biol. Chem. 1999, 274:4364-4369.
90. Yu L., Quinn M.T., Cross A.R., Dinauer M.C. Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7993-7998.
91. Yu L., Zhen L., Dinauer M.C. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits. J. Biol. Chem. 1997, 272:27288-27294.
92. Zhu Y., Marchal C.C., Casbon A.J., Stull N., von Lohneysen K., Knaus U.G., Jesaitis A.J., McCormick S., Nauseef W.M., Dinauer M.C. Deletion mutagenesis of p22phox subunit of flavocytochrome b558: identification of regions critical for gp91phox maturation and NADPH oxidase activity. J. Biol. Chem. 2006, 281:30336-30346.
93. Zou J., Sweeney C.L., Chou B.K., Choi U., Pan J., Wang H., Dowey S.N., Cheng L., Malech H.L. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 2011, 117:5561-5572.